Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
35,033
archived clinical trials in
Lung Cancer

Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
St. Joseph Mercy Cancer Center at St. Joseph Mercy Hospital
mi
from
Ann Arbor, MI
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
St. Joseph Mercy Cancer Center at St. Joseph Mercy Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Oakwood Cancer Center at Oakwood Hospital and Medical Center
mi
from
Dearborn, MI
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Oakwood Cancer Center at Oakwood Hospital and Medical Center
mi
from
Dearborn, MI
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Hurley Medical Center
mi
from
Flint, MI
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Hurley Medical Center
mi
from
Flint, MI
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Genesys Hurley Cancer Institute
mi
from
Flint, MI
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Genesys Hurley Cancer Institute
mi
from
Flint, MI
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Seton Cancer Institute - Saginaw
mi
from
Saginaw, MI
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Seton Cancer Institute - Saginaw
mi
from
Saginaw, MI
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
St. John Macomb Hospital
mi
from
Warren, MI
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
St. John Macomb Hospital
mi
from
Warren, MI
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
MeritCare Clinic - Bemidji
mi
from
Bemidji, MN
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
MeritCare Clinic - Bemidji
mi
from
Bemidji, MN
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Bryan LGH Medical Center West
mi
from
Lincoln, NE
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Bryan LGH Medical Center West
mi
from
Lincoln, NE
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Cancer Resource Center - Lincoln
mi
from
Lincoln, NE
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Cancer Resource Center - Lincoln
mi
from
Lincoln, NE
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
St. Elizabeth Regional Medical Center
mi
from
Lincoln, NE
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
St. Elizabeth Regional Medical Center
mi
from
Lincoln, NE
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Bismarck Cancer Center
mi
from
Bismarck, ND
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Bismarck Cancer Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Cancer Care Center at Medcenter One Hospital
mi
from
Bismarck, ND
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Cancer Care Center at Medcenter One Hospital
mi
from
Bismarck, ND
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Mid Dakota Clinic, PC
mi
from
Bismarck, ND
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Mid Dakota Clinic, PC
mi
from
Bismarck, ND
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
St. Alexius Medical Center
mi
from
Bismarck, ND
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
St. Alexius Medical Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - MeritCare Hospital
mi
from
Fargo, ND
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - MeritCare Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
MeritCare Medical Group
mi
from
Fargo, ND
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
MeritCare Medical Group
mi
from
Fargo, ND
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Altru Cancer Center at Altru Hospital
mi
from
Grand Forks, ND
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Altru Cancer Center at Altru Hospital
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Geisinger Medical Center
mi
from
Danville, PA
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Geisinger Medical Group
mi
from
State College, PA
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Geisinger Medical Group
mi
from
State College, PA
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Geisinger Wyoming Valley Medical Center
mi
from
Wilkes-Barre, PA
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Geisinger Wyoming Valley Medical Center
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Sioux Valley Hospital at University of South Dakota Medical Center
mi
from
Sioux Falls, SD
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Sioux Valley Hospital at University of South Dakota Medical Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Avera McKennan Hospital and University Health Center
mi
from
Sioux Falls, SD
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Avera McKennan Hospital and University Health Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
Franciscan Skemp Healthcare
mi
from
La Crosse, WI
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
Franciscan Skemp Healthcare
mi
from
La Crosse, WI
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
MBCCOP - Gulf Coast
mi
from
Mobile, AL
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
MBCCOP - Gulf Coast
mi
from
Mobile, AL
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Mayo Clinic Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Mayo Clinic Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Wichita
mi
from
Wichita, KA
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Ochsner
mi
from
New Orleans, LA
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Ochsner
mi
from
New Orleans, LA
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Michigan Cancer Research Consortium
mi
from
Ann Arbor, MI
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Michigan Cancer Research Consortium
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Duluth
mi
from
Duluth, MN
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
Coborn Cancer Center
mi
from
Saint Cloud, MN
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
Coborn Cancer Center
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
Medcenter One Health System
mi
from
Bismarck, ND
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
Medcenter One Health System
mi
from
Bismarck, ND
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Toledo Community Hospital
mi
from
Toledo, OH
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Toledo Community Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated:  7/13/2015
CCOP - St. Vincent Hospital Cancer Center, Green Bay
mi
from
Green Bay, WI
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma
Status: Enrolling
Updated: 7/13/2015
CCOP - St. Vincent Hospital Cancer Center, Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials